LCTX Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Lineage Cell Therapeutics Inc (LCTX) Moving Averages Convergence Divergence (MACD) indicator is -0.0516, suggesting LCTX is Strong Sell.

Lineage Cell Therapeutics Inc (LCTX) 20-Day simple moving average is 1.539, while Lineage Cell Therapeutics Inc (LCTX) share price is $1.37, making it Sell.

Lineage Cell Therapeutics Inc (LCTX) 60-Day simple moving average is 1.623, while Lineage Cell Therapeutics Inc (LCTX) share price is $1.37, making it Sell.

Technical Analysis for LCTX

Technical Sentiment Analysis for Lineage Cell Therapeutics Inc (LCTX) As of 2026-05-08, Lineage Cell Therapeutics Inc (LCTX) is exhibiting a Strong Sell technical sentiment. Our proprietary analysis, which aggregates 14 technical signals, shows that 4 indicators are flashing buy, while 10 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for LCTX stands at 35.597, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.0516, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 5.828 and the Commodity Channel Index (CCI) at -148.83 further confirm a -0.18 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, LCTX is trading above its 60-day moving average of $1.623 and above its 200-day long-term moving average of $1.574. Key price levels to watch include the immediate resistance at $1.634 and strong support at $1.324. A break above $1.634 could signal a bull continuation, while falling below $1.324 may test the next Fibonacci floor at $1.182.

Lineage Cell Therapeutics Inc (LCTX) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	1.014	1.182	1.324	1.492	1.634	1.802	1.944
Fibonacci	1.182	1.3	1.374	1.492	1.61	1.684	1.802

Lineage Cell Therapeutics Inc (LCTX) Technical Indicators

2026-05-08

Name	Value
RSI_14	35.597
STOCHk_14_3_3	5.828
STOCHd_14_3_3	8.619
CCI_20	-148.83
AO_5_34	-0.11
MOM_10	-0.18
MACD_12_26_9	-0.0516

Lineage Cell Therapeutics Inc (LCTX) Relative Strength Index (RSI) is 35.597, creating a Neutral signal.

Lineage Cell Therapeutics Inc (LCTX) Stochastic Oscillator is 5.828, creating a Buy signal.

Lineage Cell Therapeutics Inc (LCTX) Stochastic RSI is 8.619, creating a Buy signal.

Lineage Cell Therapeutics Inc (LCTX) Commodity Channel Index (CCI) is -148.83, creating a Buy signal.

Lineage Cell Therapeutics Inc (LCTX) Awesome Oscillator is -0.11, creating a Sell signal.

Lineage Cell Therapeutics Inc (LCTX) Momentum is -0.18, creating a Sell signal.

Lineage Cell Therapeutics Inc (LCTX) MACD is -0.0516, creating a Sell signal.

Lineage Cell Therapeutics Inc (LCTX) Moving Average

2026-05-08

Period	Simple	Signal
MA_5	1.41	Sell
MA_10	1.466	Sell
MA_20	1.539	Sell
MA_60	1.623	Sell
MA_200	1.574	Sell
MA_250	1.421	Sell

Lineage Cell Therapeutics Inc (LCTX) 5-Day simple moving average is 1.41, while Lineage Cell Therapeutics Inc (LCTX) share price is $1.37, making it a Sell.

Lineage Cell Therapeutics Inc (LCTX) 10-Day simple moving average is 1.466, while Lineage Cell Therapeutics Inc (LCTX) share price is $1.37, making it a Sell.

Lineage Cell Therapeutics Inc (LCTX) 20-Day simple moving average is 1.539, while Lineage Cell Therapeutics Inc (LCTX) share price is $1.37, making it a Sell.

Lineage Cell Therapeutics Inc (LCTX) 60-Day simple moving average is 1.623, while Lineage Cell Therapeutics Inc (LCTX) share price is $1.37, making it a Sell.

Lineage Cell Therapeutics Inc (LCTX) 200-Day simple moving average is 1.574, while Lineage Cell Therapeutics Inc (LCTX) share price is $1.37, making it a Sell.

Lineage Cell Therapeutics Inc (LCTX) 250-Day simple moving average is 1.421, while Lineage Cell Therapeutics Inc (LCTX) share price is $1.37, making it a Sell.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for LCTX?

The overall technical consensus for Lineage Cell Therapeutics Inc (LCTX) is currently Strong Sell. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 4 buy signals and 4 sell signals.

What are the key support and resistance levels for Lineage Cell Therapeutics Inc (LCTX) today?

Based on pivot point calculations, Lineage Cell Therapeutics Inc (LCTX) has an immediate support level at 1.324 and a major resistance level at 1.634. Traders also monitor the pivot point at 1.492 to determine the intraday trend direction.

Is Lineage Cell Therapeutics Inc (LCTX) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Lineage Cell Therapeutics Inc (LCTX) is currently 35.597. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Lineage Cell Therapeutics Inc (LCTX)?

Lineage Cell Therapeutics Inc (LCTX) Moving Averages Convergence Divergence (MACD) indicator is -0.0516, suggesting LCTX is Strong Sell. This indicator helps identify potential trend reversals or momentum shifts for Lineage Cell Therapeutics Inc.

How is Lineage Cell Therapeutics Inc (LCTX) performing relative to its 200-day moving average?

Lineage Cell Therapeutics Inc (LCTX) is currently trading at $1.37, which is below its 200-day simple moving average of 1.574. Trading below the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.